Avandia, a Case of Deja Vu all over again
October 14, 2005 link to pdf of original letter Dr. Russell Katz Director, Neuropharmacological Drug Products Food and Drug Administration, FDA 120 1451 Rockville Pike, Room 4037 Rockville, MD 20852 Re: FDA Neurontin Safety Analyses Dear Dr. Katz: Due to the continued public danger facing a substantial class of…
FDA Regulators Accused of Trying to Quash Testimony About Cardiac Risks of Painkillers – NYT Sat, 12 Feb 2005 A New York Times front page report announces that President Bush will veto any limits on the Medicare prescription drug giveaway. The administration is adamant about transfering $724 billion in taxpayer…
BBC reports that "Up to one in three mental health patients are being over-prescribed drugs, says the Healthcare Commission."
This is an action alert to prevent the abuse of children who are sought as guinea pigs in HIV-AIDS vaccine trials!
Two items in today’s New York Times illustrate the contrast between what the Administration claims it’s legislative / regulatory proposals will do for health care, and what they actually do after they’ve taken effect.
Minnesota Attorney General Supports Widow in Zoloft Suicide Case Tue, 22 Mar 2005 A press release from the law firm, Baum Hedlund announces that Minnesota’s State Attorney General filed a legal brief refuting Pfizer’s claim that “it should be immune from liability for failing to warn about dangerous side effects…